Neuropharmacology

Neuropharmacology publishes high quality, original research and review articles within the discipline of neuroscience, especially articles with a neuropharmacological component. However, papers within any area of neuroscience will be considered. The journal does not usually accept clinical research, although preclinical neuropharmacological studies in humans may be considered. The journal only considers submissions in which the chemical structures and compositions of experimental agents are readily available in the literature or disclosed by the authors in the submitted manuscript. Only in exceptional circumstances will natural products be considered, and then only if the preparation is well defined by scientific means.

Publisher
Elsevier
Impact factor
4.137 (2011)
Some content from Wikipedia, licensed under CC BY-SA

Neuropeptide may aid targeted anxiety therapy

The targeted control of biochemical processes and neuronal signalling pathways using the messenger substance neuropeptide Y could help in the future treatment of anxiety disorders. This is demonstrated in research findings ...

Nov 21, 2016
popularity0 comments 0